Clinical trials
Terminated beta-Thalassemia trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2005 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2014 | 2 |
| 2017 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 9 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carelon Research | 1 |
| Dana-Farber Cancer Institute | 1 |
| Fulcrum Therapeutics | 1 |
| La Jolla Pharmaceutical Company | 1 |
| Masonic Cancer Center, University of Minnesota | 1 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 1 |
| Shire | 1 |
| Sideris Pharmaceuticals | 1 |
| University of California, San Francisco | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| beta-Thalassemia | 9 |
| Anemia, Sickle Cell | 5 |
| Thalassemia | 3 |
| Hemoglobinopathies | 2 |
| Iron Overload | 2 |
| Anemia, Diamond-Blackfan | 1 |
| Cardiovascular Diseases | 1 |
| Heart Diseases | 1 |
| Hematologic Diseases | 1 |
| Hemoglobin SC Disease | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.